In addition, MicroStrategy announced it would be raising up to $2 billion via a preferred stock offering. This $2 billion ...

Cyclacel Pharmaceuticals announces securities purchase agreement with investor David Lazar, new CEO appointed, and stock up ...

Ellington Financial offers high-yield preferred shares for consistent income. Learn more about EFC's Series A or Series C ...

Fintel reports that on January 6, 2025, Baird upgraded their outlook for Prologis, Inc. - Preferred Stock (OTCPK:PLDGP) from ...

Fintel reports that on January 6, 2025, Barclays downgraded their outlook for RenaissanceRe Holdings - Preferred Stock ...

MicroStrategy Inc. bought $101 million of Bitcoin after announcing that it would use perpetual preferred stock as well as ...

Regional Health Properties, Inc. (AMEX:RHE) and SunLink Health Systems, Inc. (AMEX:SSY) shares traded higher after the ...

Regarding the dividend, Taiwo Aimasiko, Bemax CEO, commented, "Today we are rewarding our passionate and supportive shareholders with a dividend of Bemax Series A Convertible Preferred Stock. Each ...

MicroStrategy is targeting another $2 billion raise from a perpetual preferred stock offering to buy more Bitcoin, expanding ...

MicroStrategy Inc. unveiled its latest capital raise late Friday with news of plans to issue $2 billion in preferred stock to raise the funds needed to buy more bitcoin. The business-software company ...

Cyclacel Pharmaceuticals (CYCC) announced that the Company entered into a securities purchase agreement with investor David Lazar, pursuant to ...